Gut germs and pain after kidney transplant
Part of Kidney & urinary, Pain clinical trials.
This study looks at whether the germs in your gut (microbiome) and certain chemicals in your blood affect pain after a kidney transplant. By joining, you may help doctors better understand and manage pain for future kidney transplant patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are getting a kidney transplant at the University of Illinois (UI Health).
- You do not have a history of colon cancer or inflammatory bowel disease (like Crohn's or ulcerative colitis).
- You have not had a C. diff infection in the last 8 weeks.
- You are not getting a multiorgan transplant (like kidney and pancreas at the same time).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
This study looks at the bacteria living in the gut of people who have received an organ transplant. By understanding how these bacteria change after transplant, doctors hope to improve long-term health for transplant recipients.
This trial tests whether taking a probiotic supplement helps people recovering from a kidney transplant. If you are between 18 and 75 years old and had a smooth recovery in the first month after surgery, you may be able to join.
This early-phase trial tests whether giving probiotics can help reduce diarrhea caused by the immunosuppressive medications you take after a kidney transplant. If you are having diarrhea and are at least 3 months post-transplant, you may be able to join.
This study looks at how the body’s immune system responds when a kidney transplant shows signs of rejection, using a planned kidney biopsy. It may help doctors better understand what drives rejection and how to improve care in the future.
This study looks at molecular changes in kidney transplants that have microvascular inflammation (a type of injury). It aims to better understand why some transplants get this inflammation, which could lead to better treatments.
Hear when a new Gut Microbiome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.